Lianfeng Wu

530 total citations
9 papers, 434 citations indexed

About

Lianfeng Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lianfeng Wu has authored 9 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Lianfeng Wu's work include Cell death mechanisms and regulation (4 papers), DNA Repair Mechanisms (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Lianfeng Wu is often cited by papers focused on Cell death mechanisms and regulation (4 papers), DNA Repair Mechanisms (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Lianfeng Wu collaborates with scholars based in China, United States and Canada. Lianfeng Wu's co-authors include Minsheng Yuan, Alexander A. Soukas, Michael C. Kacergis, Elizabeth C. Pino, Roy E. Wuthier, Brian R. Genge, Zusen Fan, Emilio Rojas, Nelson Arispe and Honglian Zhang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biophysical Journal.

In The Last Decade

Lianfeng Wu

9 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianfeng Wu China 8 288 93 60 60 48 9 434
Choong-Chin Liew Canada 13 569 2.0× 83 0.9× 132 2.2× 80 1.3× 62 1.3× 15 844
N Takami Japan 10 312 1.1× 77 0.8× 56 0.9× 33 0.6× 60 1.3× 13 535
Prudence N’guessan France 9 188 0.7× 169 1.8× 74 1.2× 81 1.4× 105 2.2× 10 432
Anderson R. Frank United States 8 284 1.0× 46 0.5× 53 0.9× 75 1.3× 30 0.6× 10 415
Evelio Perez‐Albuerne United States 10 380 1.3× 92 1.0× 63 1.1× 62 1.0× 127 2.6× 14 721
Pushpankur Ghoshal United States 15 289 1.0× 84 0.9× 29 0.5× 88 1.5× 81 1.7× 23 520
Ivan Scudiero Italy 11 196 0.7× 215 2.3× 64 1.1× 165 2.8× 66 1.4× 15 423
Roderick K. Ferrier United Kingdom 7 219 0.8× 92 1.0× 24 0.4× 90 1.5× 180 3.8× 7 478
Tia Hirvonen Finland 7 197 0.7× 54 0.6× 32 0.5× 25 0.4× 38 0.8× 9 350
Jianfen Lu United States 10 213 0.7× 59 0.6× 22 0.4× 36 0.6× 56 1.2× 10 497

Countries citing papers authored by Lianfeng Wu

Since Specialization
Citations

This map shows the geographic impact of Lianfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianfeng Wu more than expected).

Fields of papers citing papers by Lianfeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianfeng Wu. The network helps show where Lianfeng Wu may publish in the future.

Co-authorship network of co-authors of Lianfeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lianfeng Wu. A scholar is included among the top collaborators of Lianfeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianfeng Wu. Lianfeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chen, Dong, Zheng Fan, Hengyue Zhu, et al.. (2024). Puerarin suppresses macrophage M1 polarization to alleviate renal inflammatory injury through antagonizing TLR4/MyD88-mediated NF-κB p65 and JNK/FoxO1 activation. Phytomedicine. 132. 155813–155813. 21 indexed citations
2.
Wang, Xiaoxia, et al.. (2015). A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia. Clinical Case Reports. 3(6). 448–452. 3 indexed citations
3.
Yuan, Minsheng, Elizabeth C. Pino, Lianfeng Wu, Michael C. Kacergis, & Alexander A. Soukas. (2012). Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2. Journal of Biological Chemistry. 287(35). 29579–29588. 137 indexed citations
4.
Wang, Li, Qian Li, Lianfeng Wu, et al.. (2012). Identification of SERPINB1 As a Physiological Inhibitor of Human Granzyme H. The Journal of Immunology. 190(3). 1319–1330. 34 indexed citations
5.
Hu, Deqing, Shengwu Liu, Lei Shi, et al.. (2010). Cleavage of Survivin by Granzyme M Triggers Degradation of the Survivin-X-linked Inhibitor of Apoptosis Protein (XIAP) Complex to Free Caspase Activity Leading to Cytolysis of Target Tumor Cells. Journal of Biological Chemistry. 285(24). 18326–18335. 39 indexed citations
6.
Wu, Lianfeng, Li Wang, Guoqiang Hua, et al.. (2009). Structural Basis for Proteolytic Specificity of the Human Apoptosis-Inducing Granzyme M. The Journal of Immunology. 183(1). 421–429. 21 indexed citations
7.
Lu, Hongxia, Qiang Hou, Tongbiao Zhao, et al.. (2006). Granzyme M Directly Cleaves Inhibitor of Caspase-Activated DNase (CAD) to Unleash CAD Leading to DNA Fragmentation. The Journal of Immunology. 177(2). 1171–1178. 60 indexed citations
8.
Arispe, Nelson, Emilio Rojas, Brian R. Genge, Lianfeng Wu, & Roy E. Wuthier. (1996). Similarity in calcium channel activity of annexin V and matrix vesicles in planar lipid bilayers. Biophysical Journal. 71(4). 1764–1775. 78 indexed citations
9.
Genge, Brian R., Lianfeng Wu, H. Davis Adkisson, & Roy E. Wuthier. (1991). Matrix vesicle annexins exhibit proteolipid-like properties. Selective partitioning into lipophilic solvents under acidic conditions. Journal of Biological Chemistry. 266(16). 10678–10685. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Choong-Chin Liew Breakdown of academic impact, for papers by N Takami Breakdown of academic impact, for papers by Prudence N’guessan Breakdown of academic impact, for papers by Anderson R. Frank Breakdown of academic impact, for papers by Evelio Perez‐Albuerne Breakdown of academic impact, for papers by Pushpankur Ghoshal Breakdown of academic impact, for papers by Ivan Scudiero Breakdown of academic impact, for papers by Roderick K. Ferrier Breakdown of academic impact, for papers by Tia Hirvonen Breakdown of academic impact, for papers by Jianfen Lu
Rankless by CCL
2026